S
Syed Faraz Ahmed
Researcher at Hong Kong University of Science and Technology
Publications - 23
Citations - 1567
Syed Faraz Ahmed is an academic researcher from Hong Kong University of Science and Technology. The author has contributed to research in topics: Epitope & Major histocompatibility complex. The author has an hindex of 9, co-authored 22 publications receiving 1084 citations. Previous affiliations of Syed Faraz Ahmed include King Fahd University of Petroleum and Minerals & University Health Network.
Papers
More filters
Journal ArticleDOI
Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies.
TL;DR: This study identified a set of B cell and T cell epitopes derived from the spike (S) and nucleocapsid (N) proteins that map identically to SARS-CoV-2 proteins, providing a screened set of epitopes that can help guide experimental efforts towards the development of vaccines against this novel virus.
Posted ContentDOI
Preliminary identification of potential vaccine targets for the COVID-19 coronavirus (SARS-CoV-2) based on SARS-CoV immunological studies
TL;DR: This study identified a set of B cell and T cell epitopes derived from the spike (S) and nucleocapsid (N) proteins that map identically to SARS-CoV-2 proteins, and screened these epitopes for immune targeting to potentially offer protection against this novel virus.
Journal ArticleDOI
COVIDep: a web-based platform for real-time reporting of vaccine target recommendations for SARS-CoV-2.
TL;DR: COVIDep is a first-of-its-kind web-based platform that pools genetic data for Sars-CoV-2 and immunological data for the 2003 SARS virus to identify B-cell and T-cell epitopes to serve as vaccine target recommendations for SARS-Cov-2, and identifies genetically similar SARS epitopes that can induce a human immune response.
Journal ArticleDOI
In silico T cell epitope identification for SARS-CoV-2: Progress and perspectives.
TL;DR: A review of the in-silico methods that have been used for the prediction of SARS-CoV-2 T cell epitopes is presented in this paper, where a performance comparison is provided based on the ability to identify a specific set of immunogenic epitopes that were determined experimentally to be targeted by T cells in convalescent COVID-19 patients.
Posted ContentDOI
Preliminary identification of potential vaccine targets for 2019-nCoV based on SARS-CoV immunological studies
TL;DR: In this article, a set of B cell and T cell epitopes derived from the spike (S) and nucleocapsid (N) proteins of SARS-CoV was identified and compared to 2019-nCoV proteins.